Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 3,001–3,025 of 7,816 matching trials · page 121 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Long-term Efficacy and Safety Study of GV-971 NCT05181475 Sodium Oligomannate Capsules (GV-971) Runs in: China · 40 sites |
PHASE4 other |
ACTIVE_NOT_RECRUITING | 800 | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. INDUSTRY |
2024-11-15 |
|
Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type NCT03620981 Brexpiprazole; Placebo Runs in: Japan · 1 site |
PHASE2|PHASE3 other |
COMPLETED | 410 | Otsuka Pharmaceutical Co., Ltd. INDUSTRY |
2024-11-14 |
|
Computer-Based Learning to Enhance Dementia Care in Prison NCT05497882 E-Learning Prototype for Dementia Care Runs in: United States · 2 sites |
NA other |
COMPLETED | 23 | Klein Buendel, Inc. INDUSTRY |
2024-11-14 |
|
Exploring the Diagnostic Biomarkers of Cognitive Disorders in China NCT06419101 Runs in: China · 1 site |
NA other |
RECRUITING | 3,000 | Cuibai Wei,Clinical Professor OTHER |
2024-11-14 |
|
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases NCT06539169 Runs in: United States · 1 site |
NA other |
UNKNOWN | 1,000 | xCures INDUSTRY |
2024-11-14 |
|
Efficacy of MindAhead's Digital Behavioral Activation Therapy in Adults with MCI or Mild Dementia NCT06149013 MindAhead Active; Treatment-as-usual Runs in: Germany · 1 site |
NA other |
COMPLETED | 50 | MindAhead UG INDUSTRY |
2024-11-13 |
|
Hainan Community Cognition Cohort NCT06686186 No Intervention: Observational Cohort Runs in: China · 1 site |
NA other |
RECRUITING | 2,000 | Hainan Medical College OTHER |
2024-11-13 |
|
WAVE: AudioVisual Stimulation Enhances Cognitive, Mental and Physical Health in Elderly NCT06686563 Intervention Group: Gamma stimulation; Control Group: Theta stimulation Runs in: Portugal · 1 site |
NA other |
ENROLLING_BY_INVITATION | 48 | Maria Paço OTHER |
2024-11-13 |
|
LACunar Intervention (LACI-2) Trial-2 NCT03451591 Isosorbide Mononitrate XL (ISMN); Cilostazol; ISMN XL and Cilostazo... Runs in: United Kingdom · 1 site |
PHASE2|PHASE3 other |
COMPLETED | 363 | University of Edinburgh OTHER |
2024-11-12 |
|
Clinical Study to Monitor Plasma Levels of 24OHC in Subject with HD NCT04257513 Brain MRI Runs in: Italy · 1 site |
NA other |
COMPLETED | 60 | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta OTHER |
2024-11-12 |
|
Efficacy and Safety of Flos Gossypii Flavonoids Tablet in the Treatment of Alzheimer's Disease NCT05269173 Flos gossypii flavonoids tablet Runs in: China · 19 sites |
PHASE2 other |
COMPLETED | 240 | Capital Medical University OTHER |
2024-11-12 |
|
Feasibility and Acceptability of Mindfulness-based Resilience Training for Rural Law Enforcement Officers NCT05629637 Mindfulness-Based Resilience Training (MBRT) Runs in: United States · 1 site |
NA other |
COMPLETED | 20 | Pacific University OTHER |
2024-11-12 |
|
Evaluation Study for the Chef Anchor 3.0 Program NCT06572748 10-week programme Runs in: Hong Kong · 1 site |
NA other |
RECRUITING | 136 | The University of Hong Kong OTHER |
2024-11-12 |
|
Comparison of Different Training Programs on Cognitive Function NCT06682741 Exercise Runs in: Poland · 1 site |
NA other |
ENROLLING_BY_INVITATION | 500 | Poznan University of Physical Education OTHER |
2024-11-12 |
|
Gamification in the Treatment of Spider Phobia NCT04423783 7-day exposure therapy via self-developed app according to (Haberka... Runs in: Germany · 2 sites |
NA other |
COMPLETED | 90 | Anke Haberkamp OTHER |
2024-11-08 |
|
Single Dose Escalation Study of CM383 in Healthy Volunteers NCT06412185 CM383; Placebo Runs in: China · 1 site |
PHASE1 other |
UNKNOWN | 56 | Keymed Biosciences Co.Ltd INDUSTRY |
2024-11-08 |
|
Anesthesia and Perioperative Neurocognitive Disorders in the Elderly Patients Undergoing Hip Fracture Surgery Platform Trial (ANDES Platform Trial) NCT06452147 Nerve block+standard anesthesia; Intravenous lidocaine+standard ane... Runs in: China · 1 site |
NA other |
RECRUITING | 1,860 | Second Affiliated Hospital of Wenzhou Medical University OTHER |
2024-11-08 |
|
Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder NCT06629207 PET/CT with 18-FDG; SPECT : 123 I-FP-CIT (DATSCAN); MRI Runs in: Switzerland · 1 site |
NA other |
RECRUITING | 20 | Insel Gruppe AG, University Hospital Bern OTHER |
2024-11-08 |
|
Palmitoylethanolamide Combined With Luteoline in Frontotemporal Dementia Patients. A Randomized Controlled Trial NCT04489017 PEA-LUT; PLACEBO Runs in: Italy · 2 sites |
PHASE2 other |
COMPLETED | 50 | I.R.C.C.S. Fondazione Santa Lucia OTHER |
2024-11-07 |
|
Voice and Swallowing Disorders in Adults With and Without Alzheimer's Disease NCT06328374 |
NA other |
WITHDRAWN | 0 | Vanderbilt University Medical Center OTHER |
2024-11-07 |
|
Targeting zDHHC Enzymes to Counteract Alzheimer's Disease NCT06677632 Palmitoylation Enzyme Expression Profiling Study Runs in: Italy · 1 site |
NA other |
UNKNOWN | 14 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS OTHER |
2024-11-07 |
|
Study on Aging and Cognitive Impairment in China NCT06679296 Runs in: China · 1 site |
NA other |
RECRUITING | 20,000 | First Affiliated Hospital of Wenzhou Medical University OTHER |
2024-11-07 |
|
North American Prodromal Synucleinopathy Consortium NCT03623672 Runs in: Canada; United States · 10 sites |
NA other |
ENROLLING_BY_INVITATION | 500 | Washington University School of Medicine OTHER |
2024-11-06 |
|
PainChek® US Validation Nursing Home Study NCT06049732 PainChek® Runs in: United States · 5 sites |
NA other |
COMPLETED | 105 | PainChek Ltd INDUSTRY |
2024-11-06 |
|
ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease NCT03622905 DBS-f On; DBS Off Runs in: Canada; Germany; United States · 21 sites |
NA other |
COMPLETED | 74 | Functional Neuromodulation Ltd INDUSTRY |
2024-11-05 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial